InnovAge (OTCMKTS:INNV) Hits New 52-Week High – Should You Buy?

InnovAge Holding Corp. (OTCMKTS:INNVGet Free Report) reached a new 52-week high on Wednesday . The stock traded as high as $7.15 and last traded at $6.83, with a volume of 79292 shares. The stock had previously closed at $5.66.

InnovAge Stock Performance

The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.57 and a current ratio of 1.57. The stock has a market cap of $1.02 billion, a price-to-earnings ratio of -24.19 and a beta of 0.57. The stock has a fifty day simple moving average of $5.50 and a two-hundred day simple moving average of $4.86.

About InnovAge

(Get Free Report)

InnovAge Holdings, Inc, trading under the ticker INNV on the OTC Markets, is a specialized health care services company focused on delivering comprehensive geriatric care through the Program of All-Inclusive Care for the Elderly (PACE). The company’s model is designed to provide integrated medical and social services for seniors who qualify for both Medicare and Medicaid, with an emphasis on allowing participants to remain in their homes and communities for as long as possible.

InnovAge’s core offerings include primary medical care, prescription drug coverage, rehabilitative therapies, transportation, nutritional counseling and home-based support services.

Featured Stories

Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.